IBDEI0T1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13614,2)
 ;;=^5063349
 ;;^UTILITY(U,$J,358.3,13615,0)
 ;;=Z80.43^^53^594^40
 ;;^UTILITY(U,$J,358.3,13615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13615,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,13615,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,13615,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,13616,0)
 ;;=Z80.6^^53^594^32
 ;;^UTILITY(U,$J,358.3,13616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13616,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,13616,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,13616,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,13617,0)
 ;;=Z80.8^^53^594^37
 ;;^UTILITY(U,$J,358.3,13617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13617,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,13617,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,13617,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,13618,0)
 ;;=Z81.8^^53^594^42
 ;;^UTILITY(U,$J,358.3,13618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13618,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,13618,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,13618,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,13619,0)
 ;;=Z82.3^^53^594^49
 ;;^UTILITY(U,$J,358.3,13619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13619,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,13619,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,13619,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,13620,0)
 ;;=Z82.49^^53^594^31
 ;;^UTILITY(U,$J,358.3,13620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13620,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,13620,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,13620,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,13621,0)
 ;;=Z82.5^^53^594^22
 ;;^UTILITY(U,$J,358.3,13621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13621,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,13621,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,13621,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,13622,0)
 ;;=Z82.61^^53^594^21
 ;;^UTILITY(U,$J,358.3,13622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13622,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,13622,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,13622,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,13623,0)
 ;;=Z82.69^^53^594^44
 ;;^UTILITY(U,$J,358.3,13623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13623,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,13623,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,13623,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,13624,0)
 ;;=Z83.3^^53^594^28
 ;;^UTILITY(U,$J,358.3,13624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13624,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,13624,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,13624,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,13625,0)
 ;;=Z83.2^^53^594^24
 ;;^UTILITY(U,$J,358.3,13625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13625,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,13625,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,13625,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,13626,0)
 ;;=Z82.71^^53^594^47
 ;;^UTILITY(U,$J,358.3,13626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13626,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,13626,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,13626,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,13627,0)
 ;;=Z82.1^^53^594^23
 ;;^UTILITY(U,$J,358.3,13627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13627,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
